<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="219325">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00229034</url>
  </required_header>
  <id_info>
    <org_study_id>R-05-382</org_study_id>
    <secondary_id>11652E</secondary_id>
    <nct_id>NCT00229034</nct_id>
  </id_info>
  <brief_title>Effect of APC and Epo on the Inflammatory Response During Sepsis</brief_title>
  <official_title>Effect of Activated Protein C and Erythropoietin on the Microvascular Inflammatory Response During Severe Sepsis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An observational study to determine the effect of APC and Epo in reducing the systemic
      inflammatory response during severe sepsis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An observational study to determine the effect of APC and Epo in reducing the systemic
      inflammatory response during severe sepsis. Patients already prescribed either drug will be
      enrolled. The microcirculation of the sublingual vascular bed will be observed with a
      microscope to detect the alterations in the inflammatory response.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2005</start_date>
  <completion_date type="Anticipated">September 2011</completion_date>
  <primary_completion_date type="Anticipated">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Sepsis</condition>
  <condition>Systemic Inflammation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients in the ICU in severe septic shock receiving either APC and/or Epo
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients in the ICU in severe septic shock undergoing APC and/or Epo treatment

        Exclusion Criteria:

          -  any severe comorbid conditions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amit Badhwar, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Scientist</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Neil Parry, MD</last_name>
    <role>Study Director</role>
    <affiliation>Surgeon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amit Badhwar, PhD</last_name>
    <phone>519.685.8500</phone>
    <email>amit.badhwar@uwo.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Lawson Health Research Institute</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amit Badhwar, PhD</last_name>
      <phone>519.685.8500</phone>
      <email>amit.badhwar@uwo.ca</email>
    </contact>
    <investigator>
      <last_name>Amit Badhwar, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>December 2008</verification_date>
  <lastchanged_date>December 19, 2008</lastchanged_date>
  <firstreceived_date>September 27, 2005</firstreceived_date>
  <responsible_party>
    <name_title>Dr. N. Badhwar</name_title>
    <organization>Lawson Health Research Institute</organization>
  </responsible_party>
  <keyword>Systemic Inflammation</keyword>
  <keyword>Microvascular Perfusion</keyword>
  <keyword>Septic Shock</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
